Moderna (MRNA) Other financing activities (2018 - 2026)
Moderna (MRNA) posted quarterly Other financing activities of $23.0 million for Q2 2026, up 64.29% year-over-year from $14.0 million in Q2 2025, and up 21.05% on a QoQ basis from $19.0 million in Q1 2026.
Moderna (MRNA) Other financing activities (2018 - 2026) Analysis & Trends
Moderna has reported Other financing activities for 9 years, with the latest figure at $23.0 million in Q2 2026.
- Other financing activities for Q2 2026 came in at $23.0 million, up 64.29% year-over-year; the trailing twelve-month figure through Jun 2026 was $60.0 million (up 66.67% YoY), and the FY2025 annual result was $35.0 million, down 46.97% from the prior year.
- Other financing activities rose to $23.0 million in Q2 2026, from $19.0 million in the prior quarter.
- Over five years, Other financing activities peaked at $32.0 million in Q2 2024 and troughed at $2.0 million in Q3 2025.
- A 5-year average of $14.1 million and a median of $14.5 million in 2023 frame the typical range for Other financing activities.
- The widest annual swing landed in 2025, when Other financing activities sank 80.0%; it then jumped 533.33% in 2026.
- A 5-year view of Other financing activities shows it stood at $25.0 million in 2022, then tumbled by 40.0% to $15.0 million in 2023, then fell by 26.67% to $11.0 million in 2024, then jumped by 45.45% to $16.0 million in 2025, then jumped by 43.75% to $23.0 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $23.0 million in Q2 2026, $19.0 million in Q1 2026, and $16.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.00 Mn |
| Jun 30, 2026 | 23.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |